EDX Medical Group Plc (EDX) ORD GBP0.01

EDX Medical Group Plc is a United Kingdom-based company, which develops digital diagnostic products and services for the personalized treatment for cancer, heart disease and infectious diseases. The Company provides healthcare professionals and organizations with tools and services for predicting and managing diseases on a personalized basis. It provides tests for use by professionals or individuals at point-of-care, home, or workplace. Its products and services include Caris MI Profile, cResponse, Caris MI Tumor Seek Hybrid, Caris Assure, Testicular cancer testing, Prostate cancer super test, Bowel cancer super test, Multiple biomarker 5FU/ capecitabine pharmacogenomic drug safety and treatment management test, and Polymerase chain reaction (PCR) test, among others. The Caris MI Profile platform offers artificial intelligence (AI) solutions such as Caris GPsai and Caris FOLFIRSTai to guide clinicians in diagnosis and treatment of cancer patients.